Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Randomised trial of neo-adjuvant therapy in patients with stage IIIA non small cell lung cancer
ISRCTN ISRCTN54157750
DOI 10.1186/ISRCTN54157750
ClinicalTrials.gov identifier
EudraCT number
Public title Randomised trial of neo-adjuvant therapy in patients with stage IIIA non small cell lung cancer
Scientific title
Acronym N/A
Serial number at source LU20
Study hypothesis To compare in patients with stage IIIA non small cell lung cancer a policy of standard therapy with thoracic radiotherapy versus a policy of chemotherapy followed, if feasible, by surgery
Lay summary Not provided at time of registration
Ethics approval Not provided at time of registration.
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Cancer
Participants - inclusion criteria 1. No previous treatment for the current lung cancer
2. Either sex
3. World Health Organisation (WHO) 0-2, T3N1M0 or T1-3N2M0 stage
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/09/1995
Anticipated end date 01/05/1999
Status of trial Completed
Patient information material
Target number of participants 350
Interventions 1. One group receives standard therapy with thoracic radiotherapy
2. The other group receives chemotherapy followed, if feasible, by surgery
Primary outcome measure(s) 1. Survival time
2. Quality of life
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Medical Research Council (MRC) (UK)
Trial website
Publications
Contact name Dr  Danielle  Andrews
  Address MRC Clinical Trials Unit
222 Euston Road
  City/town London
  Zip/Postcode NW1 2DA
  Country United Kingdom
  Email
Sponsor Medical Research Council (MRC) (UK)
  Address 20 Park Crescent
  City/town London
  Zip/Postcode W1B 1AL
  Country United Kingdom
  Tel +44 (0)20 7636 5422
  Fax +44 (0)20 7436 6179
  Email clinical.trial@headoffice.mrc.ac.uk
  Sponsor website: http://www.mrc.ac.uk
Date applied 28/02/2001
Last edited 30/07/2012
Date ISRCTN assigned 28/02/2001
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.